The Blood And Lymphatic Cancer: Targets And Therapy is reputed journal publishes research related to lymphoma, anticancer agents, haematology, leukaemia. The ISSN of the journal is 1179-9889.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Blood and Lymphatic Cancer: Targets and Therapy |
|---|---|
| Publisher | Dove Press |
| Publication Country | United Kingdom |
| ISSN | 1179-9889 |
| Publication Area | Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | No |
The Blood And Lymphatic Cancer: Targets And Therapy is indexed in: DOAJ, PubMed, Embase.
There is a fee to publish in the Blood And Lymphatic Cancer: Targets And Therapy. The publication fee is 2390 USD.
The journal also offers a fee waiver policy.
The Blood And Lymphatic Cancer: Targets And Therapy takes an average of 16 weeks to publish research papers.
The official website of the journal is https://www.dovepress.com/blood-and-lymphatic-cancer-targets-and-therapy-journal.
Please visit only official website of the journal to submit research papers.